Real-time enrollment status for this amyloidosis, primary clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:47 AM UTC
| NCT Number | NCT02641145 |
| Recruiting Status | Recruiting |
| Condition | Amyloidosis, Primary |
| Phase | NA |
| Target Enrollment | 171 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Brigham and Women's Hospital |
| Last Updated on CT.gov | November 14, 2025 (Nov 14, 2025) |
As of July 17, 2026: Clinical trial NCT02641145 is currently recruiting participants. This na study for amyloidosis, primary is actively seeking new participants at 1 location across the United States. The study is sponsored by Brigham and Women's Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02641145 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02641145 was last updated Nov 14, 2025 (November 14, 2025). HelloStudys verifies this status automatically.